In this two-point Scatchard-plot assay, with which a test of competitive inhibition is combined, the sample is mechanically homogenized in a buffer containing dithiothreitol, ultracentrifuged to obtain a fat-free cytosol, the protein content of which is then adjusted, and free and bound labeled estradiol are separated with dextrancoated charcoal after overnight incubation. We tested the method for precision and reliability by assaying such cytosols from pregnant rabbit uteri before and after dilution with kidney cytosol, and by assaying several other target and nontarget animal and human tissues. The Scatchard plot data were more reliable than tests for percent inhibition of binding by a competitor (diethylstilbestrol). For a tumor tissue to be judged positive it must bind at least 8 fmol of estradiol per milligram of protein and have a Kd of 0.1 to 5 X 10b0 mol/liter. Some nontarget tissues showed less than 70% inhibition by iofold concentrations (over labeled estradiol) of inhibitor.
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Of 19 breast-tumor specimens, seven were found to be positive. The clinical value of assay for estrogen receptor (also called estrogen-binding protein) in breast tumor is now well established (1) (2) (3) (4) . The results of such assay of primary or secondary tumor tissue greatly improve the selection of those breast-tumor patients who will benefit most from endocrine therapy, including endocrine ablative surgery (i.e., adrenalectomy, hypophysectomy).
Previously described assay methods for estrogen receptor include differential charcoal absorption (5) and (or) sucrose gradient elution (6) (7) (8) plot, and a binding index-all in a protocol simple enough to allow batch assay of samples from several patients and of target-and nontarget-tissue controls. We report the precision and sensitivity of the assay and guidelines for interpretation of positive results. death, trimmed, cubed, and quick-frozen in liquid nitrogen before transfer to small polyethylene bags and a -70 #{176}C freezer. Human tissues were obtained at surgery and frozen quickly with solid CO2 or liquid nitrogen.
Materials and Methods Materials
These were kept at -70 #{176}C before assaying.
Cytosol Preparation
Transfer an amount of frozen tissue weighing 0. tubes first combine diethylstilbestrol in homogenizing buffer and cytosol, mix, incubate for 30 mm in an ice-bath, and then add the labeled estradiol and mix again. Let all tubes stand at 4 #{176}C overnight and add 500 il of water to "Totals" (tubes 5, 6, 9, 10, etc.). Add 500 l of cold dextran-coated charcoal (2.5 g of Norit A and 25 mg of dextran per liter of 10 mmol/liter Tris-HC1, pH 8 at 4 #{176}C) to all remaining tubes of the set. Shake for 30 mm (at a rate of about 180 oscillations/mm) at 4-5 #{176}C. Sediment the charcoal by centrifuging at 40 000 X g at 5 #{176}C for 10 mm.
Finally transfer SOO-fd aliquots to counting vials, add 10 ml of scintillant (Beckman Ready Solv Solution VI), and determine radioactivity (10-mm counts; Searle Isocap 300; Searle Analytic, 2000 Nuclear Drive, Des Plaines, Ill. 60018). To convert counts to moles (standard count), add 1 pmol (1012 mol) of labeled estradiol in 500 zl aqueous solution and 10 ml of scintillant cocktail to two additional counting vials.
Construct a two-point Scatchard plot (11) from the data by using the following formulas:
(1) Average all duplicate counts (2) Point 1 is then given by 
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35-44 etc. To evaluate the sensitivity of the method, we performed assays on cytosols of pregnant rabbit uterus and rabbit kidney and defined mixtures of these (100%, 80%, 40%, 20% with respect to uterus and 100% kidney). The protein contents of both pure tissue cytosols were adjusted to 2 g of protein per liter before mixing and assaying. The results of this study ( Figure 2) show that the maximum bindings (x-intercepts) closely parallel the dilution of uterus estrogen receptor. Also, nont.arget kidney tissue is readily distinguished from the 20% uterus/80% kidney cytosol. We studied the precision of the assay by performing 12 complete sets of assays on the rabbit uterus, rabbit kidney, and mixtures. In these instances, cytosols were freshly prepared from original stocks of frozen tissue held at -70 #{176}C. The data (Table 3) show that some imprecision exists. Whether the concentration of receptor varies in the rabbit uterine horns and (5, 7, (13) (14) (15) was found. Diethylstilbestrol rather than unlabeled 17-estradiol was used in the assay because of its greater solubility in water.
Tissues from 19 breast-cancer patients have been assayed by this technic to date, and the data are listed in Table 5 .
DIscussIon
The present method was adapted from previously described methods (6, 10) . We assayed several target and nontarget tissues by using the seven-point The beneficial effect of this agent is discussed in the paper.
mammary tumor sary to permit the vessel holding the tissue to be kept in ice and to control frictional heating by standardized intermittent action, because heat destroys the receptor (6, 15) . The homogenizing buffer must be of low ionic strength to minimize dissociation (16) in case a gradient need be run, and must contain dithiothreitol for protection of labile sulfhydryl groups associated with the receptor activity (17, 18) . Although we did not examine the effect of dithiothreitol, one can observe in Table 6 beled estradiol of high specific activity. It was therefore necessary to include cytosol in every tube of a "set," to eliminate quenching differences within the "set."
The "blank" tubes measure "background" counts and the inefficiency of the charcoal in removing free labeled estradiol, so that reasonably true net bound counts and B/F ratios can be obtained.
The method we describe furnishes sufficient information to be able to identify the estrogen-binding protein specifically. Only those tumors found to have more than 8 fmol of labeled 17fl-estradiol per milligram of protein with a Kd less than 5 X 10_b mol/ liter are categorized as positive. The binding index correlates best when the receptor concentration is high but appears unreliable otherwise (Tables 3 and  5) . We believe that because the binding index requires only two additional tubes per tissue it is worth determining for possible corroborative value. Jensen (1) believes that a certain minimal amount of estrogen-binding protein must be present to warrant ablative surgery. Those using methods comparing competitive and noncompetitive binding (i.e., binding index) would have difficulty quantitating the receptor.
The stipulation that the Svedberg coefficient be determined appears less rigid, because 4S as well as 8S and mixed forms of estrogen receptors have been found (2, 3, 16) . Otherwise, this method generates values comparable to those of others ( Table 6 ).
The present method satisfies most of the requirements for the assay of estrogen-binding protein. Further, four tumor tissues, a positive (target tissue), and a negative (nontarget tissue) control can be assayed in only 64 tubes and in about 5 h of technician time.
